Icosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglycerides.

In patients at high cardiovascular risk, the rate of events remains elevated despite traditional, evidence-based lipid-lowering therapy. Residual hypertriglyceridemia is an important contributor to...